Effects of a number of classes of 50S inhibitors on stop codon readthrough during protein synthesis

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 12, 2004, Pages 4889-4891

  Thompson, Jill ^a,c   Pratt, Catherine A ^b   Dahlberg, Albert E ^a  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CAPREOMYCIN; CHLORAMPHENICOL; ERYTHROMYCIN; LINCOMYCIN; NALIDIXIC ACID; OLEANDOMYCIN; PEPTIDE; SPARSOMYCIN; SPIRAMYCIN; TYLOSIN;

ARTICLE; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; RIBOSOME SUBUNIT; STOP CODON;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-GALACTOSIDASE; CODON, TERMINATOR; ESCHERICHIA COLI; RIBOSOMES;

EID: 9644265316     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.12.4889-4891.2004     Document Type: Article

References (19)

1. Berisio, R., F. Schluenzen, J. Harms, A. Bashan, T. Auerbach, D. Baram, and A. Yonath. 2003. Structural insight into the role of the ribosomal tunnel in cellular recognition. Nat. Struct. Biol. 10:366-370.
2. Contreras, A., and D. Vazquez. 1977. Cooperative and antagonistic interactions of peptidyl-tRNA and antibiotics with bacterial ribosomes. Eur. J. Biochem. 74:539-547.
3. Cundliffe, E. 1981. Antibiotic inhibitors of ribosome function, p. 402-547. In E. F. Gale, E. Cundliffe, P. E. Reynolds, M. H. Richmond, and M. J. Waring (ed.), The molecular basis of antibiotic action. Wiley, London, United Kingdom.
4. Emmerson, A. M., and A. M. Jones. 2003. The quinolones: decades of development and use. J. Antimicrob. Chemother. 51(Suppl. 1):13-20.
5. Hansen, J. L., J. A. Ippolito, N. Ban, P. Nissen, P. B. Moore, and T. A. Steitz. 2002. The structures of four macrolide antibiotics bound to the large ribosomal subunit. Mol. Cell. 10:117-128.
6. Hansen, J. L., P. B. Moore, and T. A. Steitz. 2003. Structures of five antibiotics bound at the peptidyl transferase center of the large ribosomal subunit. J. Mol. Biol. 330:1061-1075.
7. Klaholz, B. P., T. Pape, A. V. Zarialov, A. G. Myasnikov, E. V. Orlova, B. Vestergaard, M. Ehrenberg, and M. van Heel. 2003. Structure of the Escherichia coli ribosomal termination complex with release factor 2. Nature 421:90-94.
8. Marrero, P., M. J. Cabanas, and J. Modolell. 1980. Induction of translational errors (misreading) by tuberactinomycins and capreomycins. Biochem. Biophys. Res. Commun. 97:1047-1052.
9. O'Connor, M., H. U. Göringer, and A. E. Dahlberg. 1992. A ribosomal ambiguity mutation in the 530 loop of E. coli 16S rRNA. Nucleic Acids Res. 20:4221-4227.
10. Pestka, S. 1974. Antibiotics as probes of ribosome structure: binding of chloramphenicol and erythromycin to polyribosomes; effect of other antibiotics. Antimicrob. Agents Chemother. 5:255-267.
11. Rawat, U. B. S., A. V. Zavlalov, J. Sengupta, M. Valle, R. A. Grassucci, J. Linde, B. Vestergaard, M. Ehrenberg, and J. Frank. 2003. A cryo-electron microscopic study of ribosome-bound termination factor RF2. Nature 421:87-90.
12. Rheinberger, H.-J., and K. H. Nierhaus. 1990. Partial release of AcPhe-Phe-[RNA from ribosomes during poly(U)-dependent poly(Phe) synthesis and the effects of chloramphenicol. Eur. J. Biochem. 193:643-650.
13. Schlünzen, F., R. Zarivach, J. Harms, A. Bashan, A. Tocilj, R. Albrecht, A. Yonath, and F. Franceschi. 2001. Structural basis for the interaction of antibiotics with the peptidyl transferase center in eubacteria. Nature 413:814-821.
14. Schlünzen, F., J. M. Harms, F. Franceschi, H. A. S. Hansen, H. Bartels, Zarivach, R., and A. Yonath. 2003. Structural basis for the antibiotic activity of ketolides and azalides. Structure 11:329-338.
15. Sievers, A., M. Beringer, M. V. Rodnina, and R. Wolfenden. 2004. The ribosome as an entropy trap. Proc. Natl. Acad. Sci. USA 101:7897-7901.
16. Tenson, T., M. Lovmar, and M. Ehrenberg. 2003. The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome. J. Mol. Biol. 330:1005-1014.
17. Thompson, J., M. O'Connor, J. A. Mills, and A. E. Dahlberg. 2002. The protein synthesis inhibitors, oxazolidinones and chloramphenicol, cause extensive translational inaccuracy in vivo. J. Mol. Biol. 322:273-279.
18. Xiong, L., P. Kloss, S. Douthwaite, N. M. Andersen, S. Swaney, D. L. Shinabarger, and A. S. Mankin. 2000. Oxazolidinone resistance mutations in 23S rRNA of Escherichia coli reveal the central region of domain V as the primary site of drug action. J. Bacteriol. 182:5325-5331.
19. Youngman, E. M., J. L. Brunelle, A. B. Kochaniak, and R. Green. 2004. The active site of the ribosome is composed of two layers of conserved nucleotides with distinct roles in peptide bond formation and peptide release. Cell 117:589-599.